RT Journal Article
SR Electronic
T1 Detection and segmentation of hyperdense middle cerebral artery sign on non-contrast CT using artificial intelligence
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.25.24311036
DO 10.1101/2024.07.25.24311036
A1 Kim, Pyeong Eun
A1 Ha, Sue Young
A1 Lee, Myungjae
A1 Kim, Nakhoon
A1 Kim, Dongmin
A1 Sunwoo, Leonard
A1 Ryu, Wi-Sun
A1 Kim, Beom Joon
YR 2024
UL http://medrxiv.org/content/early/2024/07/27/2024.07.25.24311036.abstract
AB Background The hyperdense artery sign (HAS) in patients with large vessel occlusion (LVO) is associated with outcomes after ischemic stroke. Considering the labor-intensive nature of manual segmentation of HAS, we developed and validated an automated HAS segmentation algorithm on non-contrast brain CT (NCCT) images using a multicenter dataset with independent annotations by two experts.Methods For the training dataset, we included patients with ischemic stroke undergoing concurrent NCCT and CT angiography between May 2011 and December 2022 from six stroke centers. The model was externally validated using a dataset from one stroke center. For the clinical validation dataset, a consecutive series of patients admitted within 24 hours of symptom onset were included between December 2020 and April 2023 from six stroke centers. The model was trained using a 2D U-Net algorithm with manual segmentation by two experts. We constructed models trained on datasets annotated individually by each expert, and an ensemble model using shuffled annotations from both experts. The performance of the models was compared using area under the receiver operating characteristics curve (AUROC), sensitivity, and specificity.Results A total of 673, 365, and 774 patients were included in the training, external validation, and clinical validation datasets, respectively, with mean (SD) ages of 68.8 (13.2), 67.6 (13.4), and 68.8 (13.6) years and male frequencies of 55.0%, 59.5%, and 57.6%. The ensemble model achieved higher AUROC and sensitivity compared to the models trained on annotations from a single expert in the external validation dataset. In the clinical validation dataset, the ensemble model exhibited an AUROC of 0.846 (95% CI, 0.819–0.871), sensitivity of 76.8% (65.1–86.1%), and specificity of 88.5% (85.9–90.8%). The predicted volume of the clot was significantly correlated with infarct volume on follow-up diffusion-weighted imaging (r=0.42; p<0.001).Conclusion Our algorithm promptly and accurately identifies clot signs, facilitating the screening of potential patients who may require intervention.Competing Interest StatementM.Lee, S.Ha, P.Kim, D.Kim, and W-S.Ryu are employees of JLK Inc., Seoul, Republic of Korea.Funding StatementThis research was supported by the Multiministry Grant for Medical Device Development (KMDF_PR_20200901_0098), funded by the Korean government and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI22C0454).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review boards of Seoul National University Bundang hospital approved the study and waived informed consent due to the anonymous and retrospective study design.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon request.HAShyperdense artery signNCCTnoncontrast computed tomographyLVOlarge vessel occlusionAIartificial intelligenceCTAcomputed tomography angiographyDWIdiffusion-weighted imageNIHSSNational Institutes of Health Stroke ScalemTICImodified thrombolysis in cerebral infarctionEVTendovascular treatmentmRSmodified Rankin ScaleHUHounsfield unitDSCDice similarity coefficientAUROCarea under the receiver operating characteristic curvePPVpositive predictive valueNPVnegative predictive value